{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:54:13Z","timestamp":1783655653213,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejim.2024.01.010","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T06:48:34Z","timestamp":1705819714000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-331X","authenticated-orcid":false,"given":"Asiiat","family":"Alieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8359-6599","authenticated-orcid":false,"given":"Alessia","family":"Di Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5651-3161","authenticated-orcid":false,"given":"Marta","family":"Gazzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Reutova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Usova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Bakaleiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-0883","authenticated-orcid":false,"given":"Marcello","family":"Arca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"D'Erasmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pellegatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4231-4150","authenticated-orcid":false,"given":"Federica","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7107-243X","authenticated-orcid":false,"given":"Elena","family":"Olmastroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7593-2094","authenticated-orcid":false,"given":"Alberico L","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-5361","authenticated-orcid":false,"given":"Manuela","family":"Casula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"45","key":"10.1016\/j.ejim.2024.01.010_bib0001","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ejim.2024.01.010_bib0002","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/2047487314533218","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the international FH foundation","volume":"22","author":"Watts","year":"2015","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.010_bib0003","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2004-822987","article-title":"Advanced method for the identification of patients with inherited hypercholesterolemia","volume":"4","author":"Defesche","year":"2004","journal-title":"S Semin Vasc Med"},{"key":"10.1016\/j.ejim.2024.01.010_bib0004","doi-asserted-by":"crossref","unstructured":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ. 1991;303(6807):893\u20136. 10.1136\/bmj.303.6807.893.","DOI":"10.1136\/bmj.303.6807.893"},{"issue":"3 Suppl","key":"10.1016\/j.ejim.2024.01.010_bib0005","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jacl.2011.03.452","article-title":"Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Hopkins","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.ejim.2024.01.010_bib0006","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1353\/hub.2006.0005","article-title":"Screening of APOB gene mutations in subjects with clinical diagnosis of familial hypercholesterolemia","volume":"77","author":"Merino-Ibarra","year":"2005","journal-title":"Hum Biol"},{"issue":"7","key":"10.1016\/j.ejim.2024.01.010_bib0007","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5551\/jat.RV17050","article-title":"Homozygous Familial Hypercholesterolemia","volume":"28","author":"Nohara","year":"2021","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.010_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2011.12.021","article-title":"Molecular characterization of familial hypercholesterolemia in Spain","volume":"221","author":"Palacios","year":"2012","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.ejim.2024.01.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029223","article-title":"Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia","volume":"12","author":"Olmastroni","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.ejim.2024.01.010_bib0010","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jacl.2022.09.007","article-title":"Impact of variants of uncertain significance of LDL receptor on phenotypes of familial hypercholesterolemia","volume":"16","author":"Tada","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"7","key":"10.1016\/j.ejim.2024.01.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023668","article-title":"Twelve variants polygenic score for low-density lipoprotein cholesterol distribution in a large cohort of patients with clinically diagnosed familial hypercholesterolemia with or without causative mutations","volume":"11","author":"Olmastroni","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"9874","key":"10.1016\/j.ejim.2024.01.010_bib0012","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"issue":"7307","key":"10.1016\/j.ejim.2024.01.010_bib0013","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ejim.2024.01.010_bib0014","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jacl.2021.10.001","article-title":"Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: implications for clinical diagnosis","volume":"15","author":"Di Costanzo","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ejim.2024.01.010_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosissup.2017.07.001","article-title":"Familial hypercholesterolemia: the Italian atherosclerosis society network (LIPIGEN)","volume":"29","author":"Averna","year":"2017","journal-title":"Atheroscler Suppl"},{"issue":"6","key":"10.1016\/j.ejim.2024.01.010_bib0016","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.15829\/1560-4071-2021-4538","article-title":"Implemented models and perspectives of managing lipid metabolism disorders. Concept of rare lipid disease centers","volume":"26","author":"Alieva","year":"2021","journal-title":"Russian J Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2024.01.010_bib0017","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.ejim.2024.01.010_bib0018","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","article-title":"The clinical genome resource (ClinGen) familial hypercholesterolemia variant curation expert panel consensus guidelines for LDLR variant classification","volume":"24","author":"Chora","year":"2022","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.ejim.2024.01.010_bib0019","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2017.151","article-title":"Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis","volume":"20","author":"Chora","year":"2018","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.ejim.2024.01.010_bib0020","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/01.ATV.20.9.e41","article-title":"Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype","volume":"20","author":"Bertolini","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ejim.2024.01.010_bib0021","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2013.01.007","article-title":"Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy","volume":"227","author":"Bertolini","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2024.01.010_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.912510","article-title":"The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: the LIPIGEN pediatric group","volume":"13","author":"Gazzotti","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.ejim.2024.01.010_bib0023","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosissup.2017.07.002","article-title":"Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study","volume":"29","author":"Pirillo","year":"2017","journal-title":"Atheroscler Suppl"},{"issue":"4","key":"10.1016\/j.ejim.2024.01.010_bib0024","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.3390\/ijms24043224","article-title":"Genetic heterogeneity of familial hypercholesterolemia: repercussions for molecular diagnosis","volume":"24","author":"Di Taranto","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.010_bib0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12944-018-0900-8","article-title":"Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation","volume":"17","author":"Sun","year":"2018","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ejim.2024.01.010_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2017.07.003","article-title":"The study of familial hypercholesterolemia in Italy: a narrative review","volume":"29","author":"Bertolini","year":"2017","journal-title":"Atheroscler Suppl"},{"issue":"5","key":"10.1016\/j.ejim.2024.01.010_bib0027","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.ejim.2024.01.010_bib0028","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12471-011-0076-6","article-title":"Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes","volume":"19","author":"Kusters","year":"2011","journal-title":"Neth Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.010_bib0029","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jacl.2016.11.004","article-title":"Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries","volume":"11","author":"Santos","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.ejim.2024.01.010_bib0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2007.12.024","article-title":"Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors","volume":"200","author":"Alonso","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2024.01.010_bib0031","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2021.01.008","article-title":"Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries","volume":"319","author":"Futema","year":"2021","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.010_bib0032","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2024.01.010_bib0033","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.atherosclerosissup.2021.01.007","article-title":"How registers could enhance knowledge and characterization of genetic dyslipidaemias: the experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia","volume":"42","author":"Gazzotti","year":"2020","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.ejim.2024.01.010_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.001","article-title":"Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS familial hypercholesterolaemia studies collaboration","volume":"22","author":"Vallejo-Vaz","year":"2016","journal-title":"Atheroscler Suppl"},{"issue":"12","key":"10.1016\/j.ejim.2024.01.010_bib0035","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/gim.2015.14","article-title":"The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia","volume":"17","author":"Benito-Vicente","year":"2015","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.ejim.2024.01.010_bib0036","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2796.2007.01915.x","article-title":"Characterization of novel mutations in the catalytic domain of the PCSK9 gene","volume":"263","author":"Cameron","year":"2008","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.010_bib0037","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2012.08.017","article-title":"In vitro functional characterization of missense mutations in the LDLR gene","volume":"225","author":"Silva","year":"2012","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.ejim.2024.01.010_bib0038","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jacbts.2023.03.013","article-title":"High-throughput microscopy characterization of rare LDLR variants","volume":"8","author":"Graca","year":"2023","journal-title":"JACC Basic Transl Sci"},{"issue":"7","key":"10.1016\/j.ejim.2024.01.010_bib0039","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1515\/cclm-2018-1037","article-title":"Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL\/HDL ratio","volume":"57","author":"Di Taranto","year":"2019","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"10.1016\/j.ejim.2024.01.010_bib0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"Hobbs","year":"1992","journal-title":"Hum Mutat"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T09:57:41Z","timestamp":1729245461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":40,"alternative-id":["S0953620524000165"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.01.010","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}